ACHC
Acadia Healthcare Company, Inc.
Nasdaq · CIK 1520697
Last close28.06
Daily change+1.13 (4.20%)
10 Years gain-42.61%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ACHC · STANDARD
SIC 8093 · Services-Specialty Outpatient Facilities, NEC · Fiscal year end 1231
Fundamental
45.6Momentum
n/aAcceleration
n/aConfidence
71.0Annual Revenue10
Quarterly Revenue35
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth8.0 / 25
Quality18.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet4.8 / 15
Shareholder Economics9.1 / 10
Forward Indicators5.0 / 5
Signals
Share count reductionDiluted share count declined 1.4416%.
Key Metrics
Revenue Growth TTM6.07%OK
Revenue CAGR 3Y8.27%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-1.44%OK
SBC / Revenue1%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $3.31B | n/a | n/a | $131.90M | -$439.91M | n/a | n/a | -13.28% | n/a | 90.71M |
| 2025 FY Dec 31, 2024 | $3.15B | n/a | n/a | $129.69M | -$560.69M | n/a | n/a | -17.78% | n/a | 92.06M |
| 2025 FY Dec 31, 2023 | $2.93B | n/a | n/a | $462.34M | $38.21M | n/a | n/a | 1.3% | n/a | 90.95M |
| 2024 FY Dec 31, 2022 | $2.61B | n/a | n/a | $380.57M | $84.42M | n/a | n/a | 3.23% | n/a | 91.56M |
| 2023 FY Dec 31, 2021 | $2.31B | n/a | n/a | $374.48M | $129.67M | n/a | n/a | 5.6% | n/a | 90.79M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $3.32B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-192508, 0000950170-25-103160 |
| Revenue Growth TTM | 6.07% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-192508, 0000950170-25-103160 |
| Revenue CAGR 3Y | 8.27% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-078266 |
| Revenue CAGR 5Y | 9.65% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-078266 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-192508 |
| Current Ratio | 1.71x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.06x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-192508 |
| SBC / Revenue | 1% | SBC / Revenue | OK | 0001193125-26-192508, 0000950170-25-103160 |
| Revenue per Diluted Share | $36.54 | Revenue / Diluted Shares | OK | 0001193125-26-192508, 0000950170-25-103160 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | 0001193125-26-192508, 0000950170-25-103160 |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001193125-26-078266 |